Iridex to Present at the 34th Annual Roth Conference

Rhea-AI Summary

Iridex Corporation (NASDAQ: IRIX) announced its participation in the 34th Annual Roth Conference, scheduled for March 15, 2022, at 10:00 a.m. PT / 1:00 p.m. ET. The company specializes in innovative ophthalmic laser-based medical products for treating glaucoma and retinal diseases. A live and archived webcast of the presentation will be accessible on the company's website. Iridex is recognized for its MicroPulse® technology, which offers effective treatments for various sight-threatening eye conditions, with products available in over 100 countries.

MOUNTAIN VIEW, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company plans to participate in the upcoming 34^th Annual Roth Conference.

Management is scheduled to present on Tuesday, March 15, 2022 at 10:00 a.m. PT / 1:00 p.m. ET. A live and archived webcast of the event will be available on the “Investors” section of the Company’s website at: www.iridex.com.

About Iridex
Iridex is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse^® technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the treatment of glaucoma, diabetic macular edema and other retinal diseases. Iridex products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit www.iridex.com.

Investor Relations Contact:
Leigh Salvo
(415) 937-5404
investors@iridex.com

FAQ

When will Iridex Corporation present at the Roth Conference?

Iridex Corporation will present on March 15, 2022, at 10:00 a.m. PT / 1:00 p.m. ET.

Where can I watch the Iridex Corporation webcast?

The webcast of the Iridex Corporation presentation will be available on the Investors section of their website.

What is Iridex Corporation known for?

Iridex Corporation is known for its innovative ophthalmic laser-based medical products, specifically for treating glaucoma and retinal diseases.

What technology does Iridex Corporation use for eye treatments?

Iridex Corporation utilizes MicroPulse® technology for its eye treatments, offering safe and effective solutions.

In how many countries are Iridex products available?

Iridex products are sold in more than 100 countries worldwide.